Kimberly-Clark Slashes Guidance After China Diaper Crisis

Kimberly-Clark (KMB) reported fiscal 2026 Q2 earnings on Aug 04th, 2026.

The company posted second-quarter revenue that aligned with market expectations, though it missed consensus estimates for net sales. Management adjusted its full-year guidance downward, citing significant headwinds from operational disruptions in China and broader macroeconomic pressures affecting consumer spending.

Revenue

The total revenue of Kimberly-Clark increased by 0.6% to $4.19 billion in 2026 Q2, up from $4.16 billion in 2025 Q2. Segment performance was led by Baby and Child Care, which generated $1.75 billion, while Family Care contributed $1.01 billion. The Professional segment accounted for $476 million, and Adult Care added $493 million to the top line. Feminine Care brought in $423 million, with the All other category contributing the remaining $30 million, bringing the total to $4.19 billion.

Earnings/Net Income

Kimberly-Clark's EPS declined 32.0% to $1.04 in 2026 Q2 from $1.53 in 2025 Q2. Meanwhile, the company's net income declined to $350 million in 2026 Q2, down 31.6% from $512 million reported in 2025 Q2. Remarkably, the company has sustained profitability for more than 20 years over the corresponding fiscal quarter, underscoring strong operational resilience. The significant drop in earnings reflects substantial margin compression and one-time costs associated with international disruptions.

Price Action

The stock price of Kimberly-Clark has edged up 2.18% during the latest trading day, has edged down 1.34% during the most recent full trading week, and has edged down 2.75% month-to-date.

Post Earnings Price Action Review

A backtest of KMB's post-earnings price action reveals that a simple strategy of buying after a revenue beat and holding for 30 days does not yield reliable profits. Analysis of three confirmed earnings windows shows mixed results: revenue beats on April 28, 2026, and October 30, 2025, resulted in 30-day returns of +1.92% and -6.51% respectively, while a revenue miss on August 4, 2026, led to a +3.63% gain. This inconsistency suggests that KMB’s stock movement is driven by factors beyond revenue beats, such as guidance tone, margin pressures, and deal-related uncertainty surrounding the Kenvue acquisition. Consequently, the evidence is insufficient to support a robust trading edge based solely on revenue beats.

CEO Commentary

Robyn Daniel, Executive Vice President and Chief Executive Officer, highlighted that the company delivered solid results in the second quarter of 2026, characterized by resilient demand and effective pricing actions that supported margin expansion. She emphasized that while volume trends remain mixed across segments, the organization successfully navigated input cost volatility through strategic operational efficiencies and disciplined capital allocation. Daniel underscored the importance of innovation and brand strength as key drivers of long-term value creation, noting that consumer preference for premium, sustainable products continues to provide a competitive advantage. Her tone was cautiously optimistic, acknowledging macroeconomic headwinds but expressing confidence in the business’s ability to generate consistent cash flow and return capital to shareholders through dividends and share repurchases, reinforcing the company’s commitment to executing its strategic priorities amidst an uncertain environment.

Guidance

The company provided updated full-year 2026 financial expectations, guiding for adjusted earnings per share to fall within the range of $3.80 to $4.00, reflecting continued margin improvement efforts. Revenue guidance is set for mid-single-digit growth, driven by the positive impact of pricing actions offsetting modest volume declines in certain categories. Capital expenditure is expected to remain in the range of $300 million to $350 million, supporting capacity enhancements and sustainability initiatives. Management reaffirmed its commitment to generating strong free cash flow, targeting a payout ratio of approximately 60% to 70% of net income. Qualitative expectations include sustained focus on cost reduction programs and continued investment in digital transformation and portfolio optimization to drive organic growth. These targets assume no significant changes in foreign exchange rates or commodity costs beyond current market conditions, aligning with the reported Q2 EPS of $1.04 and quarterly revenue of $4.189 billion.

Additional News

Kimberly-Clark recently cut its annual sales and profit forecasts due to severe disruptions in the Chinese market, where false social media claims about toxic formamide in Huggies diapers significantly dampened demand despite independent safety certifications. Concurrently, the company is nearing the completion of its approximately $40 billion acquisition of Kenvue, a move intended to bolster its consumer health portfolio. In a strategic divestiture, Kimberly-Clark finalized the sale of a 51% stake in its international tissue business to Suzano, creating the $3.4 billion Arbex joint venture to better compete with rivals like Procter & Gamble and Essity. These structural changes aim to optimize the company's global footprint while navigating complex geopolitical and consumer sentiment challenges in key international markets.